Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial †
Titel:
Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial †
Auteur:
Jiang, Z.F. Cristofanilli, M. Shao, Z.M. Tong, Z.S. Song, E.W. Wang, X.J. Liao, N. Hu, X.C. Liu, Y. Wang, Y. Zeng, L. Zhang, M.